Foundayo (Orforglipron) Foundayo (orforglipron), a newer oral GLP-1 receptor agonist, deviates from Oral Wegovy as it is a non-peptide GLP-1 molecule
By stimulating insulin secretion after meals, these medications help patients with type 2 diabetes maintain healthier blood glucose levels
My husband is very supportive, but I still feel guilty about it, and I still have more weight to lose I have been on Ozempic for a few months now, and I love it
There have been reports of gastroparesis (delayed gastric emptying) in some individuals, and semaglutide is not recommended in patients with severe gastroparesis
Nausea and GI side effects, which are most common during dose escalation, can persist longer than with shorter-acting drugs because the drug clears slowly
Thats not right for me. Remi Bader When she was pre-diabetic and gaining weight in 2020, Bader's doctor recommended that she try Ozempic